Bevacizumab at recurrence in high-grade glioma.

Salmaggi, Andrea; Gaviani, Paola; Botturi, Andrea; Lamperti, Elena; Simonetti, Giorgia; Ferrari, Daniela; Silvani, Antonio

Salmaggi, Andrea; Gaviani, Paola; Botturi, Andrea; Lamperti, Elena; Simonetti, Giorgia; Ferrari, Daniela; Silvani, Antonio.

Affiliation

Salmaggi A; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133 Milan, Italy. salmaggi.a@istituto-besta.it

Neurol Sci ; 32 Suppl 2: S251-3, 2011 Nov.

Article in En | MEDLINE | ID: mdl-21987287

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Brain Neoplasms/drug therapy; Glioma/drug therapy; Neoplasm Recurrence, Local/drug therapy; Antineoplastic Agents/therapeutic use; Bevacizumab; Brain Neoplasms/pathology; Glioma/pathology; Humans; Retreatment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized / Glioma / Neoplasm Recurrence, Local Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2011 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google